Description

CJC-1295 (No DAC) + Ipamorelin – 5mg / 5mg

This synergistic blend combines CJC-1295 without DAC and Ipamorelin, two peptides studied extensively for their role in stimulating natural growth hormone (GH) release. Together, they offer a potent yet controlled approach to enhancing GH pulsatility without significantly impacting cortisol or prolactin levels.

CJC-1295 without DAC is a shorter-acting GHRH analog that triggers GH release in a more physiologically aligned manner. Ipamorelin is a selective ghrelin receptor agonist (GHSR) known for its strong GH-releasing effects with minimal side effects. Their combination is often explored in models focused on tissue regeneration, muscle growth, fat metabolism, and anti-aging.

---

Mechanism of Action (Based on Preclinical Research):

• CJC-1295 (No DAC): Stimulates the pituitary to increase GH release in a pulsatile, short-duration pattern

• Ipamorelin: Binds to ghrelin receptors to amplify GH release without significantly affecting cortisol, prolactin, or appetite

• Combined action may enhance GH levels while preserving physiological feedback loops

---

Potential Benefits (Based on Preclinical Research):

• Enhanced growth hormone release and increased IGF-1

• Improved muscle recovery, fat metabolism, and sleep quality

• Support for connective tissue, skin, and bone health

• Minimal risk of side effects commonly seen with other GH secretagogues

---

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended strictly for laboratory research.